Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
X4 PharmaceuticalsFRA:48Q0 24 Days Inventory is 691.52 as of Mar. 2026, which is 9% below its 10-year median of 760.69. GuruFocus rates FRA:48Q0 with a GF Score™ of 24/100. The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, X4 Pharmaceuticals ranks worse than 89.18% on this metric.
The historical rank and industry rank for X4 Pharmaceuticals's Days Inventory or its related term are showing as below:
FRA:48Q0'
s Days Inventory Range Over the Past 10 Years
Min: 231.29 Med: 760.69 Max: 1290.09
Current: 866.51
During the past 11 years, X4 Pharmaceuticals's highest Days Inventory was 1290.09. The lowest was 231.29. And the median was 760.69.
FRA:48Q0's Days Inventory is ranked worse than 89.18% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs FRA:48Q0: 866.51
X4 Pharmaceuticals's Days Inventory
increased
from Mar. 2025 (58.02) to Mar. 2026 (691.52).
It might indicate that X4 Pharmaceuticals's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
X4 Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.13.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
X4 Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.67.
X4 Pharmaceuticals (FRA:48Q0) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
X4 Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
X4 Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
X4 Pharmaceuticals Days Inventory Related Terms
X4 Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for X4 Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:48Q0 vs CMPX, LRMR, PROK: Days Inventory Comparison
For the Biotechnology subindustry, X4 Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
X4 Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, X4 Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where X4 Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
X4 Pharmaceuticals (FRA:48Q0) has a Days Inventory of 691.52 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on X4 Pharmaceuticals and its competitors. This is near median its historical median of 760.69. Over the past decade, X4 Pharmaceuticals' Days Inventory has ranged from 231.29 to 1,290.09. According to the industry distribution chart, X4 Pharmaceuticals ranks #569 out of 638 companies in the Biotechnology industry, placing it in the top 89.2%.
Is X4 Pharmaceuticals' Days Inventory too high?
X4 Pharmaceuticals' current Days Inventory of 691.52 is near median its 10-year median of 760.69. Over the past 10 years, this metric has ranged from a low of 231.29 to a high of 1,290.09. The Biotechnology industry median Days Inventory is 183.20. X4 Pharmaceuticals' value of 691.52 is 277.5% above this industry median. Based on the distribution chart, X4 Pharmaceuticals ranks #569 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, X4 Pharmaceuticals has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does X4 Pharmaceuticals' Days Inventory compare to CMPX and LRMR?
According to the Biotechnology industry distribution chart, X4 Pharmaceuticals ranks #569 out of 638 companies for Days Inventory. This places X4 Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 183.20. X4 Pharmaceuticals' value of 691.52 is 277.5% above this benchmark. Historically, X4 Pharmaceuticals' own Days Inventory has ranged from 231.29 to 1,290.09 over the past decade. While the company's 10-year median is 760.69 vs. the industry median of 183.20, X4 Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. X4 Pharmaceuticals's current Days Inventory of 691.52 is 277.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on X4 Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. X4 Pharmaceuticals's current Days Inventory is 691.52, which is near median its own 10-year median of 760.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X4 Pharmaceuticals stock overvalued right now?
X4 Pharmaceuticals (FRA:48Q0) has a current Days Inventory of 691.52. The current Days Inventory is 691.52, which is near median its 10-year median of 760.69 and 277.5% above the Biotechnology industry median of 183.20. X4 Pharmaceuticals' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For X4 Pharmaceuticals (FRA:48Q0), the current Days Inventory is 691.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
24GF Score
Get the complete analysis for FRA:48Q0
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:48Q0 has been successfully added to your 
